Advanced therapy medicinal products (ATMPs)

Advanced therapy medicinal products (ATMPs)

What are ATMPs?

Advanced therapy medicinal products (ATMPs) are a new and innovative type of medicine that uses genes, tissues, or cells to treat or prevent diseases. They work by repairing, replacing, or supplementing damaged or diseased cells and tissues. ATMPs can be used to treat a wide range of conditions, including cancer, blood disorders, genetic diseases, and immunological diseases.

How are ATMPs classified?

ATMPs are classified into four main categories:

• Gene therapy medicinal products: These products contain genes that are introduced into a patient’s cells to treat a disease.
• Somatic cell therapy medicinal products: These products contain cells that have been manipulated in some way, such as by growing them in a laboratory or by modifying them genetically.
• Tissue engineered products: These products are made from tissues that have been engineered in a laboratory to create a new product.
• Combined ATMPs: These products contain a combination of two or more of the above types of ATMPs.

How are ATMPs regulated?

ATMPs are regulated by the European Medicines Agency (EMA) because they are a new and complex type of medicine. The EMA has a specific regulatory framework for ATMPs that ensures that they are safe, effective, and of high quality.

The benefits of ATMPs

ATMPs have the potential to revolutionize the treatment of many diseases. They offer a number of potential benefits over traditional medicines, including:

• The ability to target the root cause of a disease
• The potential for long-term or even curative effects
• The ability to improve the quality of life for patients

The challenges of ATMPs

ATMPs are also complex and expensive to develop and manufacture. There are also a number of scientific and technical challenges that need to be addressed before ATMPs can be widely used.

The future of ATMPs

ATMPs are a rapidly developing field of medicine. New ATMPs are being developed all the time, and they have the potential to transform the way we treat diseases.

Source: https://www.ema.europa.eu/en/human-regulatory-overview/advanced-therapy-medicinal-products-overview